- Investing Ideas
- /
- Global High Growth Potential Companies
Global High Growth Potential Companies
Results
8530
0 new
Companies with a Future performance score of at least 3, ordered by Future performance score.
8,530 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
MBTN | CHF 1.65 | 15.4% | -99.2% | CHF 51.0m | CHF 6.03 | PB0.3x | E95.4% | n/a | Semiconductors | ||
NEWBRY | SEK 3.94 | 20.1% | 33.1% | SEK 95.6m | SEK 8.00 | PS5.2x | E116.2% | n/a | Pharmaceuticals & Biotech | ||
NVG | zł1.84 | 1.1% | -27.8% | zł64.3m | zł3.65 | PE217.8x | E41.4% | 3.3% | Diversified Financials | ||
CRDO | US$30.43 | 2.0% | 89.7% | US$5.0b | US$35.33 | PS23.2x | E95.0% | n/a | Semiconductors | ||
AESI | US$22.29 | -1.8% | 5.9% | US$2.4b | US$26.00 | PE16.8x | E42.1% | 4.1% | Energy | ||
ICOP | €6.78 | 10.1% | n/a | €187.4m | €9.30 | PE37.1x | E49.2% | n/a | Capital Goods | ||
TVTX | US$13.87 | -4.6% | 76.5% | US$1.1b | US$17.00 | PS6x | E69.3% | n/a | Pharmaceuticals & Biotech | ||
ZVRA | US$7.12 | -5.6% | 55.1% | US$360.4m | US$20.50 | PS15.8x | E68.5% | n/a | Pharmaceuticals & Biotech | ||
TGTX | US$22.38 | -4.2% | 188.8% | US$3.3b | US$33.75 | PE33.6x | E43.5% | n/a | Pharmaceuticals & Biotech | ||
KEBNI B | SEK 1.20 | -5.1% | -0.8% | SEK 324.8m | SEK 2.20 | PS2.8x | E86.1% | n/a | Tech | ||
CALTX | SEK 206.20 | -0.1% | 114.8% | SEK 11.1b | SEK 227.50 | PS7x | E50.4% | n/a | Pharmaceuticals & Biotech | ||
AGP | €7.02 | 0.3% | 54.3% | €121.5m | €12.85 | PE17.9x | E22.1% | n/a | Capital Goods | ||
SCOL | SEK 0.14 | -1.4% | -91.1% | SEK 33.2m | n/a | PB0.7x | E75.3% | n/a | Pharmaceuticals & Biotech | ||
LAVV3 | R$8.19 | 1.4% | 18.0% | R$1.6b | R$12.98 | PE5.9x | E21.1% | 3.5% | Real Estate Management and Development | ||
AXSM | US$93.24 | 3.7% | 44.3% | US$4.3b | US$125.24 | PS15.4x | E68.9% | n/a | Pharmaceuticals & Biotech | ||
ARES | US$158.05 | 0% | 54.4% | US$48.9b | US$151.38 | PE83.4x | E32.9% | 2.4% | Diversified Financials | ||
RHM | €516.80 | 5.0% | 121.8% | €22.4b | €616.44 | PE34.4x | E27.7% | 1.1% | Capital Goods | ||
4480 | JP¥3,890.00 | 7.9% | -23.4% | JP¥125.1b | JP¥5,400.00 | PE47x | E30.4% | n/a | Healthcare | ||
7096 | JP¥1,679.00 | 1.5% | -29.5% | JP¥17.2b | n/a | PE41.7x | E38.4% | n/a | Healthcare | ||
A179900 | ₩23,750.00 | 4.2% | -12.5% | ₩375.8b | ₩60,000.00 | PS18.8x | E134.6% | 0% | Tech | ||
3006 | CN¥26.69 | 12.3% | 80.9% | CN¥11.5b | CN¥25.50 | PE40x | E24.3% | 2.1% | Household | ||
AV1 | AU$0.075 | 0% | 50.0% | AU$60.7m | n/a | PS14.2x | E144.2% | n/a | Software | ||
CUV | AU$13.99 | -2.2% | -5.2% | AU$723.2m | AU$29.17 | PE19.6x | E27.4% | 0.4% | Pharmaceuticals & Biotech | ||
A337930 | ₩12,540.00 | 20.0% | 184.4% | ₩367.6b | ₩15,000.00 | PE24x | E48.7% | 1.0% | Consumer Durables |